|
|
Gut. 2000 September; 47(3): 357–361. doi: 10.1136/gut.47.3.357. | PMCID: PMC1728053 |
Detection of Ki-ras gene point mutations in bile specimens for the differential diagnosis of malignant and benign biliary strictures J Saurin, M Joly-Pharaboz, P Pernas, L Henry, T Ponchon, and J Madjar Fédération des Spécialités Digestives, Hôpital Edouard Herriot, Lyon, France. Email: saurin/at/lyon151.inserm.fr BACKGROUND AND AIM—The present study was undertaken to determine if detection of Ki-ras gene point mutations in bile specimens could differentiate between benign and malignant biliary strictures.
PATIENTS—Bile specimens were obtained from 117 patients exhibiting a stricture of the main bile duct, the nature of which was assessed by cholangiography, histology, and follow up.
METHODS—DNA from frozen bile specimens was extracted, amplified, and tested for codon 12 point mutations of Ki-ras gene using sequence specific oligonucleotide hybridisation and mutant allele specific amplification.
RESULTS—DNA amplification was successful in 110/117 bile specimens (94%). Detection of Ki-ras gene mutations in bile specimens was positive in 24.4% (22/90) of patients with malignant strictures, in 31.4% (22/70) when only primary malignant tumours were considered, and in 4% (1/25) of patients with benign strictures. Of the 49 patients with histological specimens obtained before surgery, the sensitivity of histology, Ki-ras mutation analysis, and combined methods was 59.2%, 28.6%, and 73.5% respectively.
CONCLUSIONS—Our study showed that Ki-ras mutations may be detected in about one third of bile specimens from patients with primary tumours invading the main bile duct. Detection of such mutations appears to be specific and may help to differentiate between benign and malignant biliary strictures.
Keywords: biliary strictures; bile specimens; Ki-ras gene mutations The Full Text of this article is available as a PDF (137K). These references are in PubMed. This may not be the complete list of references from this article. - Choi BI, Lee JH, Han MC, Kim SH, Yi JG, Kim CW. Hilar cholangiocarcinoma: comparative study with sonography and CT. Radiology. 1989 Sep;172(3):689–692. [PubMed]
- Foutch PG. Diagnosis of cancer by cytologic methods performed during ERCP. Gastrointest Endosc. 1994 Mar–Apr;40(2 Pt 1):249–252. [PubMed]
- Foutch PG, Kerr DM, Harlan JR, Kummet TD. A prospective, controlled analysis of endoscopic cytotechniques for diagnosis of malignant biliary strictures. Am J Gastroenterol. 1991 May;86(5):577–580. [PubMed]
- Savader SJ, Prescott CA, Lund GB, Osterman FA. Intraductal biliary biopsy: comparison of three techniques. J Vasc Interv Radiol. 1996 Sep–Oct;7(5):743–750. [PubMed]
- Rustgi AK, Kelsey PB, Guelrud M, Saini S, Schapiro RH. Malignant tumors of the bile ducts: diagnosis by biopsy during endoscopic cannulation. Gastrointest Endosc. 1989 May–Jun;35(3):248–251. [PubMed]
- Ponchon T, Gagnon P, Berger F, Labadie M, Liaras A, Chavaillon A, Bory R. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc. 1995 Dec;42(6):565–572. [PubMed]
- Kurzawinski TR, Deery A, Dooley JS, Dick R, Hobbs KE, Davidson BR. A prospective study of biliary cytology in 100 patients with bile duct strictures. Hepatology. 1993 Dec;18(6):1399–1403. [PubMed]
- Howell DA, Parsons WG, Jones MA, Bosco JJ, Hanson BL. Complete tissue sampling of biliary strictures at ERCP using a new device. Gastrointest Endosc. 1996 May;43(5):498–502. [PubMed]
- Lurie BB, Loewenstein MS, Zamcheck N. Elevated carcinoembryonic antigen levels and biliary tract obstruction. JAMA. 1975 Jul 28;233(4):326–330. [PubMed]
- Pearce S, Thornes H, Carr D, Tanner A. Diagnostic pitfall; interpretation of CA 19-9 concentrations in the presence of hepatic dysfunction. Gut. 1994 May;35(5):707–708. [PubMed]
- Laurent-Puig P, Lubin R, Semhoun-Ducloux S, Pelletier G, Fourre C, Ducreux M, Briantais MJ, Buffet C, Soussi T. Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases. Gut. 1995 Mar;36(3):455–458. [PubMed]
- Sears RJ, Duckworth CW, Decaestecker C, Bourgeois N, Ledent T, Deviere J, Salmon I, Kiss R, Yeaton P. Image cytometry as a discriminatory tool for cytologic specimens obtained by endoscopic retrograde cholangiopancreatography. Cancer. 1998 Apr 25;84(2):119–126. [PubMed]
- Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology. 1994 Oct;107(4):1147–1153. [PubMed]
- Hruban RH, Sturm PD, Slebos RJ, Wilentz RE, Musler AR, Yeo CJ, Sohn TA, van Velthuysen ML, Offerhaus GJ. Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients. Am J Pathol. 1997 Oct;151(4):943–949. [PubMed]
- Bos JL. ras oncogenes in human cancer: a review. Cancer Res. 1989 Sep 1;49(17):4682–4689. [PubMed]
- Villanueva A, Reyes G, Cuatrecasas M, Martínez A, Erill N, Lerma E, Farré A, Lluís F, Capellá G. Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses. Gastroenterology. 1996 May;110(5):1587–1594. [PubMed]
- Ajiki T, Onoyama H, Yamamoto M, Fujimori T, Maeda S, Saitoh Y. Detection of point mutations in K-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary strictures. Int J Pancreatol. 1995 Dec;18(3):215–220. [PubMed]
- Lee JG, Leung JW, Cotton PB, Layfield LJ, Mannon PJ. Diagnostic utility of K-ras mutational analysis on bile obtained by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc. 1995 Oct;42(4):317–320. [PubMed]
- Hasegawa Y, Takeda S, Ichii S, Koizumi K, Maruyama M, Fujii A, Ohta H, Nakajima T, Okuda M, Baba S, et al. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA). Oncogene. 1995 Apr 6;10(7):1441–1445. [PubMed]
- Desa LA, Akosa AB, Lazzara S, Domizio P, Krausz T, Benjamin IS. Cytodiagnosis in the management of extrahepatic biliary stricture. Gut. 1991 Oct;32(10):1188–1191. [PubMed]
- Tada M, Omata M, Ohto M. High incidence of ras gene mutation in intrahepatic cholangiocarcinoma. Cancer. 1992 Mar 1;69(5):1115–1118. [PubMed]
- Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CJ. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res. 1991 Jul 1;51(13):3497–3502. [PubMed]
- Imai M, Hoshi T, Ogawa K. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer. 1994 Jun 1;73(11):2727–2733. [PubMed]
- Van Laethem JL, Bourgeois V, Parma J, Delhaye M, Cochaux P, Velu T, Devière J, Cremer M. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases. Gastrointest Endosc. 1998 Jun;47(6):479–485. [PubMed]
|
